The Norrsken Foundation, a non-profit impact ecosystem “connecting founders with the capital, knowledge and network they need to make saving the world their business,” is launching a $3.22 (€3) million initiative to support Swedish startups developing psychedelic-assisted mental health treatment options.

“Norrsken Mind” is the name for the new psychedelic science initiative that has already raised over €3 million, and is certain that more capital will come in soon enough.

The funding joins other European funding efforts in the field, such as the latest $285 million private placement raised by London-based COMPASS Pathways (NASDAQ: CMPS).

See Also: Awakn Life Sciences Becomes Pure R&D …

Full story available on

A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.